BDBM293999 3-(4-(5-((4-((2S)-1-(1H- Tetrazol-5-yl)pent-3-yn-2- yl)phenoxy)methyl)benzo[b] thiophen-3-yl)-3- methylphenoxy)propane-1,2- diol::US10106553, Compound 31

SMILES CC#C[C@@H](Cc1nnn[nH]1)c1ccc(OCc2ccc3scc(-c4ccc(OCC(O)CO)cc4C)c3c2)cc1

InChI Key InChIKey=GHHBLQRICGZMLQ-UHFFFAOYSA-N

Data  3 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 293999   

TargetFree fatty acid receptor 1(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM293999(US10106553, Compound 31 | 3-(4-(5-((4-((2S)-1-(1H-...)
Affinity DataEC50:  29nMT: 2°CAssay Description:Compounds were tested in a calcium flux assay using transfected HEK293 cells stably expressing either human GPR40 or rat GPR40. Human GPR40 expressin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
Go to US Patent

TargetFree fatty acid receptor 1(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM293999(US10106553, Compound 31 | 3-(4-(5-((4-((2S)-1-(1H-...)
Affinity DataEC50:  29nMAssay Description:Agonist activity at human GPR40 assessed as increase in intracellular calcium flux by cell based FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2020
Entry Details Article
PubMed
LigandPNGBDBM293999(US10106553, Compound 31 | 3-(4-(5-((4-((2S)-1-(1H-...)
Affinity DataEC50:  19nMAssay Description:Agonist activity at rat GPR40 assessed as increase in intracellular calcium flux by cell based FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2020
Entry Details Article
PubMed